Danish Research Institute of Translational Neuroscience - DANDRITE, Aarhus University, Aarhus C, Denmark.
Department of Biomedicine, Aarhus University, Aarhus C, Denmark.
Sci Rep. 2022 Mar 8;12(1):3737. doi: 10.1038/s41598-022-07706-2.
Dimethyl sulfoxide (DMSO) is a highly utilized small molecule that serves many purposes in scientific research. DMSO offers unique polar, aprotic and amphiphilic features, which makes it an ideal solvent for a wide variety of both polar and nonpolar molecules. Furthermore, DMSO is often used as a cryoprotectant in cell-based research. However, recent reports suggest that DMSO, even at low concentration, might interfere with important cellular processes, and cause macromolecular changes to proteins where a shift from α-helical to β-sheet structure can be observed. To investigate how DMSO might influence current research, we assessed biochemical and cellular impacts of DMSO treatment on the structure of the aggregation-prone protein α-synuclein, which plays a central role in the etiology of Parkinson's disease, and other brain-related disorders, collectively termed the synucleinopathies. Here, we found that addition of DMSO increased the particle-size of α-synuclein, and accelerated the formation of seeding-potent fibrils in a dose-dependent manner. These fibrils made in the presence of DMSO were indistinguishable from fibrils made in pure PBS, when assessed by proteolytic digestion, cytotoxic profile and their ability to seed cellular aggregation of α-synuclein. Moreover, as evident through binding to the MJFR-14-6-4-2 antibody, which preferentially recognizes aggregated forms of α-synuclein, and a bimolecular fluorescence complementation assay, cells exposed to DMSO experienced increased aggregation of α-synuclein. However, no observable α-synuclein abnormalities nor differences in neuronal survival were detected after oral DMSO-treatment in either C57BL/6- or α-synuclein transgenic F28 mice. In summary, we demonstrate that low concentrations of DMSO makes α-synuclein susceptible to undergo aggregation both in vitro and in cells. This may affect experimental outcomes when studying α-synuclein in the presence of DMSO, and should call for careful consideration when such experiments are planned.
二甲基亚砜(DMSO)是一种用途广泛的小分子,在科学研究中具有多种用途。DMSO 具有独特的极性、非质子性和两亲性特征,使其成为各种极性和非极性分子的理想溶剂。此外,DMSO 常用于基于细胞的研究中的细胞保护剂。然而,最近的报告表明,DMSO 即使在低浓度下,也可能干扰重要的细胞过程,并导致蛋白质的大分子变化,观察到从α-螺旋结构向β-折叠结构的转变。为了研究 DMSO 如何影响当前的研究,我们评估了 DMSO 处理对易聚集蛋白α-突触核蛋白结构的生化和细胞影响,α-突触核蛋白在帕金森病和其他与大脑相关的疾病(统称为突触核蛋白病)的发病机制中起核心作用。在这里,我们发现添加 DMSO 以剂量依赖的方式增加了 α-突触核蛋白的颗粒大小,并加速了具有成核潜力的纤维的形成。通过蛋白酶消化、细胞毒性谱和它们诱导 α-突触核蛋白细胞聚集的能力来评估,在 DMSO 存在下形成的这些纤维与在纯 PBS 中形成的纤维无法区分。此外,通过与 MJFR-14-6-4-2 抗体结合,该抗体优先识别 α-突触核蛋白的聚集形式,以及双分子荧光互补测定法,暴露于 DMSO 的细胞经历了 α-突触核蛋白的聚集增加。然而,在用 C57BL/6-或 α-突触核蛋白转基因 F28 小鼠进行口服 DMSO 处理后,无论是在体外还是在细胞中,均未观察到 α-突触核蛋白的异常或神经元存活的差异。总之,我们证明低浓度的 DMSO 使 α-突触核蛋白易于在体外和细胞中发生聚集。这可能会影响在 DMSO 存在下研究 α-突触核蛋白的实验结果,并且在计划进行此类实验时应谨慎考虑。